Intelligent Insulin Management Platform

An innovative system integrating AI, IoT, blockchain, and new materials to optimize insulin administration and improve patient outcomes

The original patent's insulin management system, while effective, has limitations in data accuracy, security, and patient engagement. The new inventive concept addresses these limitations by incorporating cutting-edge technologies to create a more comprehensive and personalized insulin management platform.

The Intelligent Insulin Management Platform combines a blockchain-based patient data management module with an AI-driven clinical decision support system, IoT-enabled continuous glucose monitoring, and a cloud-based data analytics platform. This integrated system enables real-time monitoring, personalized insulin dosing, and secure data storage. The platform also features a wearable device with integrated IoT sensors, a natural language processing (NLP) module, and a mobile app for patient engagement.

The new inventive concept's integration of AI, IoT, blockchain, and new materials with the original insulin management system provides a non-obvious and novel approach to optimizing insulin administration. The inventive step lies in the synergistic combination of these distinct technologies to create a more powerful and effective system.

Alternative embodiments of the Intelligent Insulin Management Platform could include the use of different AI algorithms, various IoT sensor configurations, or alternative blockchain architectures. Additionally, the platform could be adapted for use in different healthcare settings or for managing other chronic conditions.

The Intelligent Insulin Management Platform has significant commercial potential in the healthcare industry, particularly in the areas of diabetes management and personalized medicine. The platform's ability to improve patient outcomes, reduce healthcare costs, and enhance patient engagement makes it an attractive solution for healthcare providers, pharmaceutical companies, and medical device manufacturers.